Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Photodynamic Therapy for Facial Rejuvenation Combined Amber LED and Infrared Laser Irradiation: A Pilot Study Comparing ALA and MAL.

Created on 11 Aug 2026

Authors

Tassia Joi Martins, Juliana Teixeira Pedroso, Bruno Henrique Godoi, Juliana Guerra Pinto, Juliana Ferreira-Strixino

Published in

Journal of biophotonics. Volume 19. Issue 8. Pages e70335.

Abstract

The skin performs essential functions between the internal and external environments of the human body, such as protection against microorganisms, substances and radiation, maintenance of body temperature, prevention of excessive water loss, and production of vitamin D. However, many of these functions are reduced with aging and can be accentuated in photoaged skin. Photodynamic therapy (PDT) is a noninvasive technique used in the treatment of cancer, microbial infections, precancerous changes and for cosmetic purposes. Research on topical PDT suggests antibacterial, anti-inflammatory and immunomodulatory effects on keratinocytes, fibroblasts, sebaceous glands and hair follicles. Therefore, this pilot study evaluated PDT on the face using 5-aminolevulinic acid (ALA) and methyl 5-aminolevulinate (MAL), combined with amber LED and laser irradiation in women aged 40-55 years. PDT was effective in rejuvenating photoaged skin, reducing fine lines, smoothing wrinkles, and improving skin softness, firmness and sagging, with minimal side effects.

PMID:
42575720
Bibliographic data and abstract were imported from PubMed on 11 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement